Pharmacology

Action Mechanism of Action Reference
AGONIST Insulin receptor agonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetes Mellitus 3 D003920 ClinicalTrials
Diabetes Mellitus, Type 1 3 D003922 ClinicalTrials
Hyperglycemia 3 D006943 ClinicalTrials
Hypertension 3 D006973 ClinicalTrials
Diabetes Mellitus, Type 2 3 D003924 ClinicalTrials
Atherosclerosis 3 D050197 ClinicalTrials
Hypercholesterolemia 3 D006937 ClinicalTrials
Coronary Disease 3 D003327 ClinicalTrials

Related Entries

Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Injury, poisoning and procedural complications
10.65
Nervous system disorders
9.58
Metabolism and nutrition disorders
8.58
Pregnancy, puerperium and perinatal conditions
8.44
General disorders and administration site conditions
8.16
Investigations
7.88
Endocrine disorders
7.45
Vascular disorders
5.3
Cardiac disorders
3.68
Skin and subcutaneous tissue disorders
3.57
Gastrointestinal disorders
3.31
Respiratory, thoracic and mediastinal disorders
3.06
Product issues
2.92
Eye disorders
2.86
Infections and infestations
2.32
Psychiatric disorders
2.21

Cross References

Resources Reference
ChEMBL CHEMBL1201540